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Abstract
Objective: The study examined changes in and relationship between body mass index (BMI), leptin
and adiponectin levels over a 3-year period in a pediatric population-based cohort.
Study design: A 3-year prospective cohort study of 268 boys and 251 girls aged 9–10 in Ina,
Saitama, Japan.
Results: Median body mass index (BMI) significantly increased from baseline (age 9–10) to follow
up (age 12–13) in boys from 17.1 to 18.3 kg/m2 (P < 0.001) and in girls from 16.5 to 18.5 kg/m2 (P
< 0.001), respectively. Adiponectin values significantly decreased from baseline to follow up in boys
(13.5 to 8.9 μg/ml, respectively) (P < 0.001) and in girls (12.4 to 9.5 μg/ml, respectively) (P < 0.001).
L e p t i n  v a l u e s  a t  f o l l o w  u p  s i gnificantly decreased from baseline in boys (4.9 to 2.3 ng/dl,
respectively) (P < 0.001) and also in girls (5.3 to 5.1 ng/dl, respectively) (P = 0.049).
A relatively strong correlation was seen in BMI (Spearman's correlation coefficient, r = 0.864, P <
0.001 in boys; r = 0.873, P < 0.001 in girls), adiponectin (r = 0.705, P < 0.001 in boys; r = 0.695, P <
0.001 in girls), and leptin (r = 0.449, P < 0.001 in boys; r = 0.610, P < 0.001 in girls) before and after
the three-year period.
The ratio of follow up to baseline BMI was negatively correlated with that for adiponectin (r = -
0.224, P < 0.001 in boys; r = -0.165, P = 0.001 in girls) and positively correlated with that for leptin
(r = 0.518, P < 0.001 in boys; r = 0.609, P < 0.001 in girls).
Conclusion: This study demonstrated that baseline adiponectin, leptin and BMI values measured
at ages 9–10 correlated with those measured three years later. However, adiponectin values
decreased and leptin values increased in those subjects whose BMI increased during over this
period.
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Introduction
The prevalence of pediatric obesity is rising sharply
throughout the world, with marked increases also seen in
Asia, including Japan [1-3]. While some studies have
shown childhood obesity to be a risk factor for the devel-
opment of adult obesity [4-6] as has low birth weight [7].
Another study has reported that less than half of the pedi-
atric obese cases go on to become obese adults [8]. There-
fore there is no clear consensus to the role of pediatric
obesity in the development of adult obesity and no clear
answers to questions such as what is the age of onset of
pediatric obesity that leads to adult cardiovascular disease
(CAD), and when intervention should be in initiated in
obese children in order to prevent CAD.
Whitaker RC et al. [4] reported that the risk of childhood
obesity progressing to adult obesity rises markedly after
the age of 10. In Finland, an intervention study was con-
ducted in which the intake of lipids was restricted, begin-
ning at 7 months after birth. Results of this study
demonstrated a significant difference in the incidence of
obesity between the control and intervention groups after
the age of 8 [9,10]. Another report has demonstrated that
adult CAD patients tended to have low birth weight, with
a lower-than-average BMI up to age 2, with a subsequent
sharp increase in body weight before age 11, with the
authors citing this growth pattern as a risk factor [7].
In our study, we focused on the 3-year-period correspond-
ing to the ages during which the onset of obesity is most
likely to lead to either adult obesity or CAD [4,7,10].
Within a specific region we were able to target almost all
the children in this age group, studying changes in their
body mass index (BMI), adiponectin and leptin levels, as
well as the relationship between these values during the 3-
year period to investigate any correlation between changes
in these parameters and the development of obesity.
Methods
This study was conducted as part of a pediatric health pro-
motion program [11-14] initiated in 1994 in Ina, Saitama
Prefecture, Japan. Ina is approximately 30 km to the north
of Tokyo with a population of 35,000 comprising both
farmers and residents who commute to work in Tokyo. In
addition to annual national health checkups performed in
accordance with the School Health Law, Ina has a unique
health-promotion program in place. Of the fourth and
seventh graders who had undergone regular health check-
ups, those who volunteered to take part in the program
underwent blood and physical examinations.
The subjects of this study were children aged 9–10 who, in
September 1999 or 2000, were all in the fourth grade in 3
elementary schools in town, and who agreed to partici-
pate in the study. A total of 304 boys and 282 girls took
part in the study's initial survey (100% registration rate).
A follow-up survey was conducted when the subjects
reached the seventh grade (ages 12–13).
At the time of the initial and follow-up surveys, the sub-
jects underwent blood tests including leptin and adi-
ponectin measurements and physical measurements that
included height and weight.
Adiponectin was measured in accordance with a report by
Arita et al using commercially available ELISA kits
(Otsuka Pharmaceutical Co., Ltd., Japan) with intra- and
inter-assay coefficients of variation below 10% [15]. Lep-
tin was measured using commercially available RIA kits
(Linco Research Inc.) with intra- and inter-assay coeffi-
cients of variation below 10% [16]. BMI was used as an
index for obesity status.
All values were expressed as median and interquartile
range (IQR). The Kruskal-Wallis test was used to evaluate
statistical significance.
Baseline values for each of the variables examined (leptin,
adiponectin and BMI) were recorded when the subjects
were 9–10 years old. These values were again measured
three years later when the children were aged 12–13 (see
Table 1). The ratio of the baseline compared to follow-up
values were examined for each test variable. Spearman's
correlation coefficient was used to evaluate any correla-
tion between these values. Statistical analyses were made
using the SPSS program.
Table 1: The median (interquartile range) for body mass index (BMI), adiponectin (μg/ml) and leptin (ng/dl) in the study participants at 
ages 9–10 and 12–13
Age group 9–10-year-old 12–13-year-old
(n) Boys (268) Girls (251) Total (519) Boys Girls Total
BMI (kg/m2) 17.1 (15.7–18.7) 16.5 (15.2–18.3) 16.7 (15.4–18.7) 18.3** (16.9–19.8) 18.5** (17.0–20.3) 18.4** (17.0–20.1)
Adiponectin (μg/ml) 13.5 (9.6–18.2) 12.4 (9.5–16.5) 12.9 (9.6–17.5) 8.9** (6.9–11.3) 9.5** (7.4–11.8) 9.3** (7.2–11.6)
Leptin (ng/dl) 4.9 (3.2–7.8) 5.3 (3.8–9.2) 5.0 (3.5–8.5) 2.3** (1.6–3.6) 5.1* (3.6–7.9) 3.5** (2.1–6.0)
* P < 0.05, ** P < 0.001, vs. values measured at ages 9–10 yearsCardiovascular Diabetology 2009, 8:30 http://www.cardiab.com/content/8/1/30
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The study protocol was approved by two independent
institutional review boards (IRB) at Jikei University
School of Medicine and Showa University School of Med-
icine. Written informed consent was obtained from all
study participants and their guardians.
Results
Follow-up rates
Of the 586 children, follow-up physical and laboratory
examination was performed on 519 subjects three years
later (follow-up rate, 88.6%). Relocation was the major
reasons that children were lost to follow-up. There was no
statistical difference in baseline values between those
available for follow-up and those lost to follow-up in gen-
der (P = 0.512) and BMI (P = 0.958).
Values measured at ages 9–10 and at ages 12–13
Body mass index (BMI) was significantly increased and
adiponectin and leptin significantly decreased among
study participants for both genders before and after the
three-year follow-up. The mean baseline BMI value (kg/
m2) for boys was 17.1 (15.7–18.7) increasing to 18.3
(16.9–19.8) at follow up (P < 0.001), and 16.5 (15.2–
18.3) increasing to 18.5 (17.0–20.3) in girls (P < 0.001)
respectively. The mean baseline adiponectin value (μg/
ml) in boys dropped from 13.5 (9.6–18.2) to 8.9 (6.9–
11.3) at follow up (P < 0.001), and dropped from 12.4
(9.5–16.5) to 9.5 (7.4–11.8) in girls (P < 0.001) respec-
tively. The mean baseline leptin value (ng/dl) dropped
from 4.9 (3.2–7.8) to 2.3 (1.6–3.6) in boys (P < 0.001)
compared to a respective drop from 5.3 (3.8–9.2) to 5.1
(3.6–7.9) in girls (P = 0.049).
Correlation analysis
Baseline BMI, adiponectin and leptin values measured at
ages 9–10 years demonstrated a significant positive corre-
lation with those measured three year later at follow up:
BMI (boys, r  = 0.864, P  < 0.001; girls, r  = 0.873, P  <
0.001); adiponectin (boys, r = 0.705, P < 0.001; girls, r =
0.695, P < 0.001), and leptin (boys, r = 0.449, P < 0.001;
girls, r = 0.610, P < 0.001) (Figure 1).
A negative correlation was found for the ratios of follow
up to baseline adiponectin with that for BMI in both
males and females (boys, r = -0.224, P < 0.001; girls, r = -
0.165, P = 0.001). In contrast a positively correlation was
reported for the follow up to baseline leptin ratio with
that for BMI in both sexes (boys, r = 0.518, P < 0.001; girls,
r = 0.609, P < 0.001) (Figure 2).
Discussion
It is generally believed that obese children will progress to
become obese adults [4-7] with reports demonstrating
that the greater the age at which a child is obese, the
greater the link to adult obesity [4,5,17,18]. In addition,
the risk of child obesity progressing to adult obesity
increases especially after the age of 10 [4]. Thus, in this
study, we focused on the 3-year period between the ages
of 9–10 and 12–13 representing the greatest risk group
and investigated changes in BMI, leptin, and adiponectin.
Correlation in BMI, adiponectin and leptin between their values at ages 9 – 10 and their values measured at 12 – 13 by gender  in the 519 children living in the town of Ina Figure 1
Correlation in BMI, adiponectin and leptin between their values at ages 9 – 10 and their values measured at 12 
– 13 by gender in the 519 children living in the town of Ina. Boys (+): n = 268 Girls (m): n = 251. r: Spearman's rank 
correlation coefficients.Cardiovascular Diabetology 2009, 8:30 http://www.cardiab.com/content/8/1/30
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This study targeted all eligible children living in a typical
Japanese town with little population movement. This
study was distinctive in that it prospectively followed
changes in adipokines in a childhood population-based
cohort over a 3-year period. The study results demon-
strated that adiponectin, leptin and BMI values measured
at baseline (9–10 years) correlated with those measured
three years later. Therefore, these three variables measured
at ages 9–10 were predictive for results obtained three
years later, suggesting that in this age group these variables
were likely to be genetically determined. However, adi-
ponectin values were relatively decreased and leptin val-
ues relatively increased in children whose BMI increased
during the 3-year period. Of note, Cambuli VM et al.
reported that adiponectin and leptin were positive meta-
bolic outcome markers following lifestyle intervention in
overweight and obese children [19].
The current study showed that adiponectin values meas-
ured at ages 12–13 were lower than at ages 9–10. Similar
findings have been reported in Germany and in USA,
showing that adiponectin values in post-pubertal children
are lower than in pre-pubertal children, especially in boys,
which is explained by the elevated serum androgen levels
in the former [20,21]. Other reports of age-related effects
on adiponectin show that the adiponectin value drops in
a 2-year-old to a greater extent than in a 1-year-old [22],
and that the adiponectin values do not change in women
aged 18 to 80 [23].
This study also demonstrated that the leptin values at ages
12–13 were lower than those at ages 9–10, especially in
boys. Leptin values, which correlate with the amount of
body fat present, are reported to increase in girls and
decrease in boys after Tanner stage 2 as the pubertal devel-
opments proceeds [24]. Another study conducted in 2- to
5-year-old Tsimané children showed that the correlation
between body fat and leptin increases markedly with
advancing age in females [25]. The lower levels of leptin
in boys may partly be explained by the suppressive effect
of androgens in the boys [24]. However, our study
showed no age-related increase in leptin values in girls.
The current study examined changes in BMI and adipocy-
tokines in Japanese children. Differences in adipocy-
tokines between ethnic groups have been demonstrated in
previous reports in the literature [26,27]. Therefore, these
ethnic differences should be taken into account when the
results of this study are used for international compari-
sons.
Ratio of the values for BMI, adiponectin and leptin measured at ages 9 – 10 to those measured at 12 – 13, and their correlation  by gender in the 519 children living in the town of Ina Figure 2
Ratio of the values for BMI, adiponectin and leptin measured at ages 9 – 10 to those measured at 12 – 13, and 
their correlation by gender in the 519 children living in the town of Ina. Boys (+): n = 268, Girls (m): n = 251. r: 
Spearmans' correlation coefficients. Ratio: values measured at ages 12–13/values measured at ages 9–10. Straight line, medians 
for boys; dotted line, medians for girls. Adiponectin: r = -0.224, P < 0.001 in boys, r = -0.165, P = 0.001 in girls. Leptin: r = 
0.518, P < 0.001 in boys, r = 0.609, P < 0.001 in girls.Cardiovascular Diabetology 2009, 8:30 http://www.cardiab.com/content/8/1/30
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Limitations of this study include the lack of confirmation
of pubertal stage (Tanner's stages) of all subjects, as this
would have been useful to correlate with the data
obtained; this was an observational study covering a spe-
cific 3-year period and therefore the values obtained for
the metabolic markers may not necessarily be linked
directly to adult obesity. This study examined the relation-
ship between the changes in test variables and obesity,
and did not take the subjects' lifestyles into consideration.
Therefore, evaluation of lifestyle factors is an issue that
needs to be addressed in the future.
In conclusion we demonstrated in a Japanese population-
based childhood cohort that baseline adiponectin, leptin
and BMI values measured at ages 9–10 correlated with
those measured three years later. In addition, those chil-
dren with an increase in BMI over this period were also
found to have decreased adiponectin and increased leptin
values. These results suggest that lifestyle intervention in
obese children should be initiated between ages 9 and 12.
It is hoped that continued follow-up of the study partici-
pants will help identify potential methods of preventing
the onset of visceral obesity and CAD in adulthood.
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